Patent ID: 6686384
Filing Date: 2004-02-03
Classification: A61P,C07D

Abstract:
A compound selected from:2-(2,6-dichlorophenylamino)-1H-benzimidazol-4-ol; (1H-benzimidazol-2-yl)-(2-chloro-6-methylphenyl)amine; (2,6-dichlorophenyl)-(5,6-difluoro-1H-benzimidazol-2-yl)amine; (2,6-dichlorophenyl)-(4-methyl-1H-benzimidazol-2-yl)amine; (1H-benzimidazol-2-yl)-(2-chloro-6-fluorophenyl)amine; (1H-benzimidazol-2-yl)-(2,6-dibromophenyl)amine; 2-(2,6-dichlorophenylamino)-5-fluorobenzimidazole; 2-(2,6-dichlorophenylamino)-4-fluorobenzimidazole; 2-(2-trifluoromethyl-6-chlorophenylamino)benzimidazole; 2-(2,6-dichlorophenylamino)-4,5-difluorobenzimidazole; 2-(2,6-dichlorophenylamino)-5 hydroxybenzimidazole; 2-(2,6-dichlorophenylamino)-4,5,6,7-tetrafluorobenzimidazole; or 2-(2,6-dichlorophenylamino)-4,6-difluorobenzimidazole; or a pharmaceutically tolerable salt or trifluoroacetate thereof.